| Sensitivity | Specificity | PPV | NPV | MCC |
---|---|---|---|---|---|
% (95%CI) | % (95%CI) | % (95%CI) | % (95%CI) | ||
WHO non-laboratory model | |||||
 Cut-off point of 20% for laboratory-based and non-laboratory-based models | |||||
  Male | |||||
   All males | 59.0 (50.6–67.3) | 98.8 (98.4–99.2) | 68.7 (60.2–77.2) | 98.2 (97.7–98.7) | 0.61 |
    < 60 years old | 25.7 (11.2–40.2) | 99.8 (99.6–100) | 64.3 (39.2–89.4) | 99.0 (98.6–99.4) | 0.40 |
   ≥ 60 years old | 70.7 (61.7–79.7) | 93.3 (91.1–95.6) | 69.3 (60.3–78.3) | 93.7 (91.5–95.9) | 0.64 |
  Female | |||||
   All females | 35.5 (25.8–45.2) | 99.6 (99.3–99.8) | 70.2 (57.1–83.3) | 98.3 (97.9–98.7) | 0.49 |
    < 60 years old | 35.7 (10.6–60.8) | 100 (99.9–100) | 83.3 (53.5–100) | 99.8 (99.5–99.9) | 0.54 |
   ≥ 60 years old | 35.4 (24.9 -45.9) | 97.5 (96.2–98.9) | 68.3 (54.1–82.5) | 91.0 (88.6–93.4) | 0.44 |
 Cut-off point of 20% for laboratory-based and 10% for non-laboratory-based model | |||||
  Male | |||||
   All males | 99.8 (95.2–1.00) | 76.6 (75.1–78.1) | 15.6 (13.2–18.1) | 99.9 (99.7–100) | 0.34 |
    < 60 years old | 91.4 (82.2–100) | 87.4 (86.1–88.7) | 9.0 (6.1–12.0) | 99.9 (99.7–100) | 0.27 |
   ≥ 60 years old | 100 (100–100) | 17.0 (13.6–20.4) | 20.4 (16.9–24.1) | 100 (100–100) | 0.19 |
  Female | |||||
   All females | 100 (100–100) | 83.2 (82.0–84.4) | 13.5 (11.0–16.1) | 100 (100–100) | 0.33 |
    < 60 years old | 100 (100–100) | 94.3 (93.5–95.1) | 7.5 (3.7–11.0) | 100 (100–100) | 0.27 |
   ≥ 60 years old | 100 (100–100) | 19.9 (16.5–23.3) | 15.7 (12.5–18.9) | 100 (100–100) | 0.18 |